Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 2/20 | 0.35 |
| ▸ | CA2 | P00918 | 2/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | CA7 | P43166 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2608233 | 0.86 | MEN1 (0.41) | MEN1POLBKMT2ATDP1CA1 | |
| SCHEMBL2608236 | 0.85 | MEN1 (0.39) | MEN1POLBKMT2ATDP1CA1 | |
| SCHEMBL21437125 | 0.84 | MEN1 (0.42) | MEN1POLBKMT2ATDP1CA1 | |
| SCHEMBL1785606 | 0.82 | CA1 (0.41) | MEN1POLBKMT2ATDP1CA1 | |
| SCHEMBL2201821 | 0.80 | MEN1 (0.44) | MEN1POLBKMT2ATDP1CA1 | |
| SCHEMBL8940424 | 0.80 | CA1 (0.39) | MEN1POLBKMT2ATDP1CA1 | |
| SCHEMBL2203063 | 0.80 | MEN1 (0.39) | MEN1POLBKMT2ATDP1CA1 | |
| SCHEMBL153914 | 0.79 | POLB (0.52) | MEN1POLBKMT2ATDP1CA1 | |
| SCHEMBL28515472 | 0.79 | MEN1 (0.38) | MEN1POLBKMT2ATDP1CA1 | |
| SCHEMBL29605028 | 0.79 | MEN1 (0.42) | MEN1POLBKMT2ATDP1CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109863222-B | Quantum dot dispersion, self-luminous photosensitive resin composition containing same, color filter manufactured by using same, and image display device | 东友精细化工有限公司 | 2022-05-06 | — | — | CN | claimed |
| CN-109863222-A | Quantum dot dispersion, self-luminous photosensitive resin composition containing same, color filter manufactured by using same, and image display device | 东友精细化工有限公司 | 2019-06-07 | — | — | CN | claimed |
| US-11807022-B2 | Hybrid wet on wet printing methods | KAO CORPORATION (JP) | 2023-11-07 | — | — | US | disclosed |
| US-11771689-B2 | Cereblon modulators and uses thereof | VIVIDION THERAPEUTICS, INC. (US) | 2023-10-03 | — | — | US | disclosed |
| EP-3601452-B1 | RADIATION CURABLE INK COMPOSITIONS, PRINTED ARTICLES, AND METHODS OF USING THE SAME | KAO CORP (JP) | 2023-09-13 | — | — | EP | disclosed |
| EP-3775064-B1 | IN-LINE PRIMER PRINTING METHODS | KAO CORP (JP) | 2023-09-13 | — | — | EP | disclosed |
| US-20230075719-A1 | AQUEOUS ENERGY CURABLE INKJET INKS | KAO CORPORATION (JP) | 2023-03-09 | — | — | US | disclosed |
| CN-112672887-B | Hybrid wet-on-wet printing process | 花王株式会社 | 2023-02-28 | — | — | CN | disclosed |
| CN-113471526-B | Multilayer structure composite electrolyte and solid-state lithium battery | 郑州宇通集团有限公司 | 2022-12-23 | — | — | CN | disclosed |
| US-11479684-B2 | Radiation curable inkjet ink compositions, printed articles, and thermal inkjet methods of using the same | KAO CORPORATION (JP) | 2022-10-25 | — | — | US | disclosed |
| CN-114929812-A | Aqueous energy curable inkjet inks | 花王株式会社 | 2022-08-19 | — | — | CN | disclosed |
| US-20110233464-A1 | POLYMERIZABLE LIQUID CRYSTAL COMPOUND, POLYMERIZABLE LIQUID CRYSTAL COMPOSITION, POLYMER AND FILM | FUJIFILM CORPORATION (JP) | 2011-09-29 | — | — | US | disclosed |
| US-20110237768-A1 | POLYMERIZABLE LIQUID CRYSTAL COMPOUND, POLYMERIZABLE LIQUID CRYSTAL COMPOSITION, POLYMER AND FILM | FUJIFILM CORPORATION (JP) | 2011-09-29 | — | — | US | disclosed |
| US-7977402-B2 | Photocation polymerization initiator, a free-radical photoinitiator; an acrylate ester of a carboxylic acid ester; and material containing a radiation curable functional group; imppulse printheads | COLLINS INK CORPORATION (US) | 2011-07-12 | — | — | US | disclosed |
| US-20110140041-A1 | POLYMERIZABLE LIQUID CRYSTAL COMPOUNDS, POLYMERIZABLE LIQUID CRYSTAL COMPOSITIONS, LIQUID CRYSTALLINE POLYMERS AND OPTICALLY ANISOTROPIC MATERIALS | ZEON CORPORATION (JP) | 2011-06-16 | — | — | US | disclosed |
| US-20100258764-A1 | POLYMERIZABLE LIQUID CRYSTAL COMPOUND, POLYMERIZABLE LIQUID CRYSTAL COMPOSITION, LIQUID CRYSTALLINE POLYMER, AND OPTICAL ANISOTROPIC ARTICLE | ZEON CORPORATION (JP) | 2010-10-14 | — | — | US | disclosed |
| EP-2152437-A1 | RADIATION CURABLE INKS | Collins Ink Corporation (US) | 2010-02-17 | — | — | EP | disclosed |
| WO-2008045478-A1 | RADIATION CURABLE INKJETTABLE ADHESIVE | HEXION SPECIALTY CHEMICALS, INC. (US) | 2008-04-17 | — | — | WO | disclosed |
| WO-2008045480-A1 | RADIATION CURABLE INKS | HEXION SPECIALTY CHEMICALS, INC. (US) | 2008-04-17 | — | — | WO | disclosed |
| US-20080090930-A1 | Photocation polymerization initiator, a free-radical photoinitiator; an acrylate ester of a carboxylic acid ester; and material containing a radiation curable functional group; imppulse printheads | HEXION SPECIALTY CHEMICALS, INC. | 2008-04-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110140041-A1 | POLYMERIZABLE LIQUID CRYSTAL COMPOUNDS, POLYMERIZABLE LIQUID CRYSTAL COMPOSITIONS, LIQUID CRYSTALLINE POLYMERS AND OPTICALLY ANISOTROPIC MATERIALS | CCNB1, CCNT1, CCNB2 | MEN1 876/4885POLB 885/4885KMT2A 3348/4885 |
| US-20100258764-A1 | POLYMERIZABLE LIQUID CRYSTAL COMPOUND, POLYMERIZABLE LIQUID CRYSTAL COMPOSITION, LIQUID CRYSTALLINE POLYMER, AND OPTICAL ANISOTROPIC ARTICLE | LEO1, ZYX, CCNT1 | MEN1 2693/4885POLB 1029/4885KMT2A 3634/4885 |
| US-11771689-B2 | Cereblon modulators and uses thereof | CRBN, CBFB, CNN2 | MEN1 1672/4885POLB 4508/4885KMT2A 3580/4885 |
| US-20110237768-A1 | POLYMERIZABLE LIQUID CRYSTAL COMPOUND, POLYMERIZABLE LIQUID CRYSTAL COMPOSITION, POLYMER AND FILM | SCO2, NR0B2, NR0B1 | MEN1 918/4885POLB 776/4885KMT2A 2612/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.